Literature DB >> 1092797

Clonal dominance. I. Restricted nature of the IgM antibody response to group A streptococcal carbohydrate in mice.

D E Briles, J M Davie.   

Abstract

The IgM antibody response of mice to the streptococcal group A carbohydrate (GAC) was measured. With most strains tested, large amounts of IgM antibody were produced; in AKR mice, over 1% of the total nucleated spleen cells secreted IgM anti-GAC antibody after hyperimmunization. The relative avidity of the antibody was extimated by a modification of the Jerne plaque assay where spleen cells from individual mice were tested against erythrocytes with varying GAC epitope densitymthese studies showed that the earliest, as well as latest, IgM antibodies produced were highly restricted in avidity heterogeneity. No evidence of affinity maturation was seen upon hyperimmunization. These data favor the conclusion that the restricted IgG response seen in mice hyperimmunized to GAC is not the result of affinity driven competition for antigen among precursor cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1092797      PMCID: PMC2189844          DOI: 10.1084/jem.141.6.1291

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  50 in total

Review 1.  Analogies between lymphocyte receptors and the resulting humoral antibodies.

Authors:  O Mäkelä
Journal:  Transplant Rev       Date:  1970

2.  Variation in the group-specific carbohydrate of group A streptococci. I. Immunochemical studies on the carbohydrates of variant strains.

Authors:  M McCARTY; R C LANCEFIELD
Journal:  J Exp Med       Date:  1955-07-01       Impact factor: 14.307

3.  Selection of a single antibody-forming cell clone and its propagation in syngeneic mice.

Authors:  B A Askonas; A R Williamson; B E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  1970-11       Impact factor: 11.205

4.  Mouse antibodies to group A streptococcal carbohydrate; use of idiotypy to detect inbred strain specificity and to monitor spleen cell transfer in syngenetic mice.

Authors:  D E Briles; R M Krause
Journal:  J Immunol       Date:  1972-12       Impact factor: 5.422

5.  Adsorption of 3H-fatty acid esters of streptococcal groups A and E cell wall polysaccharide antigens by red blood cells and their effect on hemagglutination.

Authors:  O Pavlovskis; H D Slade
Journal:  J Bacteriol       Date:  1969-11       Impact factor: 3.490

6.  Receptors on immunocompetent cells. V. Cellular correlates of the "maturation" of the immune response.

Authors:  J M Davie; W E Paul
Journal:  J Exp Med       Date:  1972-03-01       Impact factor: 14.307

7.  Studies on the regulation of avidity at the level of the single antibody-forming cell. The effect of antigen dose and time after immunization.

Authors:  B Andersson
Journal:  J Exp Med       Date:  1970-07-01       Impact factor: 14.307

8.  STUDIES ON HUMAN ANTIBODIES. I. STARCH GEL ELECTROPHORESIS OF THE DISSOCIATED POLYPEPTIDE CHAINS.

Authors:  G M EDELMAN; E A KABAT
Journal:  J Exp Med       Date:  1964-03-01       Impact factor: 14.307

9.  Further studies on the chemical basis for serological specificity of Group A streptococcal carbohydrate.

Authors:  M McCARTY
Journal:  J Exp Med       Date:  1958-09-01       Impact factor: 14.307

10.  STUDIES ON HUMAN ANTIBODIES. II. DISTRIBUTION OF GENETIC FACTORS.

Authors:  J C ALLLEN; H G KUNKEL; E A KABAT
Journal:  J Exp Med       Date:  1964-03-01       Impact factor: 14.307

View more
  11 in total

1.  Purification and chemical characterization of the heat-stable enterotoxin produced by porcine strains of enterotoxigenic Escherichia coli.

Authors:  J F Alderete; D C Robertson
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

2.  Monoclonal antibodies against Enterocytozoon bieneusi of human origin.

Authors:  Abhineet S Sheoran; Xiaochuan Feng; Inderpal Singh; Susan Chapman-Bonofiglio; Sabrina Kitaka; Joel Hanawalt; John Nunnari; Keith Mansfield; James K Tumwine; Saul Tzipori
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

3.  Improved diagnostic accuracy using monoclonal antibody group A streptococcal carbohydrate.

Authors:  M H Nahm; P R Murray; B L Clevinger; J M Davie
Journal:  J Clin Microbiol       Date:  1980-10       Impact factor: 5.948

4.  Subclass restriction of murine antibodies. III. Antigens that stimulate IgG3 in mice stimulate IgG2c in rats.

Authors:  G P Der Balian; J Slack; B L Clevinger; H Bazin; J M Davie
Journal:  J Exp Med       Date:  1980-07-01       Impact factor: 14.307

5.  Clonotypic analysis of human antibodies specific for Neisseria meningitidis polysaccharides A and C in adults.

Authors:  S Le Moli; P M Matricardi; I Quinti; T Stroffolini; R D'Amelio
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

6.  Antipolysaccharide antibodies of restricted heterogeneity secreted by a single lymph node.

Authors:  H Frost; D G Braun; D Poskitt; R N Cahill; Z Trnka
Journal:  J Exp Med       Date:  1976-03-01       Impact factor: 14.307

7.  Distinct functions of monoclonal IgG antibody depend on antigen-site specificities.

Authors:  W Schalch; J K Wright; L S Rodkey; D G Braun
Journal:  J Exp Med       Date:  1979-04-01       Impact factor: 14.307

8.  Clonal nature of the immune response. II. The effect of immunization on clonal commitment.

Authors:  D E Briles; J M Davie
Journal:  J Exp Med       Date:  1980-07-01       Impact factor: 14.307

9.  Non-dinitrophenyl-binding immunoglobulin that bears a dominant idiotype (Id460) associated with antidinitrophenyl antibody is specific for an antigen on Pasteurella pneumotropica.

Authors:  T N Marion; E A Dzierzak; H S Lee; R L Adams; C A Janeway
Journal:  J Exp Med       Date:  1984-01-01       Impact factor: 14.307

10.  Subclass restriction of murine antibodies. II. The IgG plaque-forming cell response to thymus-independent type 1 and type 2 antigens in normal mice and mice expressing an X-linked immunodeficiency.

Authors:  J Slack; G P Der-Balian; M Nahm; J M Davie
Journal:  J Exp Med       Date:  1980-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.